carbon tetrachloride has been researched along with 3,4-dihydroxyphenyllactic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, H; Li, K; Qin, C; Qu, W | 1 |
| Cao, G; Jiang, T; Kwan, HY; Su, T; Tang, D; Zhu, R | 1 |
2 other study(ies) available for carbon tetrachloride and 3,4-dihydroxyphenyllactic acid
| Article | Year |
|---|---|
Danshensu-mediated protective effect against hepatic fibrosis induced by carbon tetrachloride in rats.
Topics: Animals; Body Weight; Carbon Tetrachloride; Cytoprotection; Lactates; Liver; Liver Cirrhosis; Liver Function Tests; Male; Organ Size; Rats; Rats, Wistar | 2014 |
Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling.
Topics: Animals; Carbon Tetrachloride; Cell Line; Enzyme Inhibitors; Hepatic Stellate Cells; Indoleamine-Pyrrole 2,3,-Dioxygenase; Janus Kinase 2; Lactates; Liver Cirrhosis, Experimental; Male; Molecular Docking Simulation; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor; Transforming Growth Factor beta1 | 2019 |